Covid infections and hospital detections are rising in Spain as autumn begins. The increase is still mild, but it is putting renewed focus on protection for vulnerable groups.
Covid is gaining ground in Spain as autumn begins. SiVIRA figures for week 37 show infections, positive tests and mild hospital admissions all moving higher. The increase has not led to a new wave of severe illness. But the virus is back at the centre of respiratory surveillance.
The contrast with other seasonal viruses is clear. Influenza and Respiratory Syncytial Virus remain at low levels. SARS-CoV-2 is already rising. That points to a Covid increase rather than a wider surge in respiratory viruses.
In primary care, the Covid-19 syndrome rate rose from 8.0 to 11.3 cases per 100,000 during 7–13 September 2026. SARS-CoV-2 test positivity increased from 15% to 16.7% over the same week.
Primary-care data show more acute respiratory infections compatible with Covid than in the previous week. Spain's ISCIII and its SiVIRA surveillance system recorded a Covid-19 syndrome rate of 11.3 per 100,000 in week 37, up from 8.0. Test positivity also rose, reaching 16.7% from 15%.
Hospitals are seeing the same trend. More patients admitted with severe acute respiratory infections are testing positive for SARS-CoV-2. The share of admissions linked to the virus is also rising, though only gradually.
The hospital system is not facing a similar escalation. Among patients admitted with severe acute respiratory infection, the share testing positive for SARS-CoV-2 rose to 15% from 11.6%. Covid hospital incidence remained low at about 1.2 per 100,000, although it was almost twice the previous week's level.
Healthcare pressure remains stable. The surveillance data show no sign of greater severity. The current pattern is wider circulation and more detection, not a sudden worsening of the disease. For the public, that means closer monitoring rather than alarm.
The overall rate of acute respiratory infections in primary care was 261.1 per 100,000, below the epidemic threshold. This indicates a specific early Covid increase rather than a broad surge of respiratory viruses across Spain.
Virological surveillance has found no sign of a sharp variant replacement behind the rise. The circulating variants remain broadly stable. Seasonal and social conditions are therefore more likely to be driving the increase than a sudden change in the virus itself.
People are returning to workplaces and schools. Mobility has increased after the summer, and more time is being spent indoors. Those changes create the conditions for transmission to pick up.
This is not an isolated September episode. Since 2022, Spain has repeatedly recorded smaller waves as people return to their usual routines. Similar increases appeared in weeks 36 and 37 of 2023, followed by a short wave in early September 2024. The rise in 2025 was smaller, but it followed the same seasonal pattern. The 2026 episode again brings more infections, detections and mild admissions without a major impact on hospitals.
The current signal is epidemiological rather than an emergency alert of the kind described in earlier reporting. Its practical importance is that Covid has started rising while flu and RSV remain quiet. That gives health authorities more time to watch the start of winter before several viruses begin circulating together. The European Centre for Disease Prevention and Control also included respiratory-virus developments in its week 38 report, giving Spain's September increase a wider EU/EEA context.
ISCIII experts also point to more social contact in enclosed spaces as a recurring factor. Warm temperatures have not stopped the shift associated with autumn. People are returning to indoor routines even while summer conditions continue.
Some specialists are also reporting more cases of tonsillitis, particularly among children and working-age adults. That does not change the main surveillance finding: Covid is currently driving the rise in respiratory viruses.
The risk is not evenly distributed. Older people, immunocompromised patients and those with chronic conditions remain more exposed to serious consequences. Accumulated immunity from vaccination and previous infections still helps protect against severe disease, but it does not prevent reinfection.
The experts cited in the report are calling for stronger seasonal vaccination among vulnerable groups. They also support access to different vaccine platforms as the virus evolves.
Spain is entering the colder season with a familiar warning. Covid has not disappeared, and its first autumn rise has arrived before the usual influenza and RSV wave. Stable variants and limited hospital pressure make this a manageable development, not a crisis.
Ignoring the increase would still be a mistake. The evidence supports targeted vaccination, close surveillance and extra care around people whose age or health leaves them less able to withstand another infection. Reports on the seasonal campaign say vaccination against flu and Covid-19, and against RSV where indicated, is due to begin on 28 September 2026 in care homes and centres for people with disabilities.
